Research Projects & Grants

For Profit Organization

• A Phase 3, Multicenter, Double Blind Active-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod Compared to Oral Fingolimod in Children and Adolescents with Relapsing Remitting Multiple Sclerosis, Role: Investigator, Celgene, Inc., (11/2025 - 11/2026) Status: Approved